CMS Should Strengthen Its Prescription Drug Event Guidance to Clarify Reporting of Sponsor Margin for Medicare Part D Bids

Submitting OIG:

Date Issued:

Monday, November 22, 2021

Agency Reviewed / Investigated:

Submitting OIG-Specific Report Number:

A-03-17-00001

Component, if applicable:

Centers for Medicare & Medicaid Services

Type of Report:

Audit

Questioned Costs:

Funds for Better Use:

Number of Recommendations:

Related Open Recommendations

Recommendation Number	Recommendation Status	Significant Recommendation	Additional Details
271283	Open	No
We recommend that the Centers for Medicare & Medicaid Services update its PDE guidance to address margin under sponsor delivery models in which a sponsor owns a pharmacy.